Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 1990. Upgrade now.
Date Value
September 30, 2024 1.341B
June 30, 2024 1.432B
March 31, 2024 722.00M
December 31, 2023 1.160B
September 30, 2023 1.008B
June 30, 2023 968.40M
March 31, 2023 817.80M
December 31, 2022 1.197B
September 30, 2022 1.316B
June 30, 2022 852.10M
March 31, 2022 973.50M
December 31, 2021 2.229B
September 30, 2021 1.632B
June 30, 2021 3.099B
March 31, 2021 1.115B
December 31, 2020 1.149B
September 30, 2020 842.10M
June 30, 2020 897.30M
March 31, 2020 624.60M
December 31, 2019 792.00M
September 30, 2019 669.60M
June 30, 2019 193.10M
March 31, 2019 461.10M
December 31, 2018 820.40M
September 30, 2018 594.70M
Date Value
June 30, 2018 551.40M
March 31, 2018 478.00M
December 31, 2017 173.51M
September 30, 2017 388.32M
June 30, 2017 387.74M
March 31, 2017 248.93M
December 31, 2016 253.09M
September 30, 2016 264.80M
June 30, 2016 196.22M
March 31, 2016 181.38M
December 31, 2015 154.99M
September 30, 2015 210.40M
June 30, 2015 194.64M
March 31, 2015 76.02M
December 31, 2014 90.10M
September 30, 2014 83.38M
June 30, 2014 96.35M
March 31, 2014 68.30M
December 31, 2013 86.18M
September 30, 2013 141.31M
June 30, 2013 87.38M
March 31, 2013 98.87M
December 31, 2012 470.41M
September 30, 2012 191.47M
June 30, 2012 76.74M

Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

624.60M
Minimum
Mar 2020
3.099B
Maximum
Jun 2021
1.208B
Average
1.062B
Median

Net Income (Quarterly) Benchmarks

Amgen Inc 2.83B
Eli Lilly and Co 970.30M
Pfizer Inc 4.465B
Biogen Inc 388.50M
AbbVie Inc 1.561B